108 related articles for article (PubMed ID: 29233784)
1. Altered natural killer cell cytokine profile in type 2 autoimmune hepatitis.
Mele D; Bossi G; Maggiore G; Oliviero B; Mantovani S; Bonelli B; Mondelli MU; Varchetta S
Clin Immunol; 2018 Mar; 188():31-37. PubMed ID: 29233784
[TBL] [Abstract][Full Text] [Related]
2. IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
Sim GC; Liu C; Wang E; Liu H; Creasy C; Dai Z; Overwijk WW; Roszik J; Marincola F; Hwu P; Grimm E; Radvanyi L
Cancer Immunol Res; 2016 Nov; 4(11):983-994. PubMed ID: 27697858
[TBL] [Abstract][Full Text] [Related]
3. Innate inflammation drives NK cell activation to impair Treg activity.
Dean JW; Peters LD; Fuhrman CA; Seay HR; Posgai AL; Stimpson SE; Brusko MA; Perry DJ; Yeh WI; Newby BN; Haller MJ; Muir AB; Atkinson MA; Mathews CE; Brusko TM
J Autoimmun; 2020 Mar; 108():102417. PubMed ID: 32035746
[TBL] [Abstract][Full Text] [Related]
4. Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37.
Sarhan D; Hippen KL; Lemire A; Hying S; Luo X; Lenvik T; Curtsinger J; Davis Z; Zhang B; Cooley S; Cichocki F; Blazar BR; Miller JS
Cancer Immunol Res; 2018 Jul; 6(7):766-775. PubMed ID: 29784636
[TBL] [Abstract][Full Text] [Related]
5. Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells.
Bergmann C; Wild CA; Narwan M; Lotfi R; Lang S; Brandau S
Eur J Immunol; 2011 Dec; 41(12):3564-73. PubMed ID: 21905023
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis.
McEachern E; Carroll AM; Fribourg M; Schiano TD; Hartzell S; Bin S; Cravedi P; Levitsky J
J Autoimmun; 2021 May; 119():102629. PubMed ID: 33721837
[TBL] [Abstract][Full Text] [Related]
7. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.
Peiseler M; Sebode M; Franke B; Wortmann F; Schwinge D; Quaas A; Baron U; Olek S; Wiegard C; Lohse AW; Weiler-Normann C; Schramm C; Herkel J
J Hepatol; 2012 Jul; 57(1):125-32. PubMed ID: 22425700
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic recruitment of cytotoxic NK cells contributes to autoimmune hepatitis progression.
Xiao F; Ai G; Yan W; Wan X; Luo X; Ning Q
Cell Immunol; 2018 May; 327():13-20. PubMed ID: 29551191
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis.
Støy S; Dige A; Sandahl TD; Laursen TL; Buus C; Hokland M; Vilstrup H
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G269-76. PubMed ID: 25501547
[TBL] [Abstract][Full Text] [Related]
10. A programmed switch from IL-15- to IL-2-dependent activation in human NK cells.
Pillet AH; Bugault F; Thèze J; Chakrabarti LA; Rose T
J Immunol; 2009 May; 182(10):6267-77. PubMed ID: 19414780
[TBL] [Abstract][Full Text] [Related]
11. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis.
Ferri S; Longhi MS; De Molo C; Lalanne C; Muratori P; Granito A; Hussain MJ; Ma Y; Lenzi M; Mieli-Vergani G; Bianchi FB; Vergani D; Muratori L
Hepatology; 2010 Sep; 52(3):999-1007. PubMed ID: 20683931
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
13. Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy.
Diestelhorst J; Junge N; Schlue J; Falk CS; Manns MP; Baumann U; Jaeckel E; Taubert R
PLoS One; 2017; 12(7):e0181107. PubMed ID: 28700730
[TBL] [Abstract][Full Text] [Related]
14. Cytokine sensitivity of human NK cells during immunosenescence. 2. IL2-induced interferon gamma secretion.
Krishnaraj R; Bhooma T
Immunol Lett; 1996 Apr; 50(1-2):59-63. PubMed ID: 8793560
[TBL] [Abstract][Full Text] [Related]
15. Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways.
Dybkaer K; Iqbal J; Zhou G; Geng H; Xiao L; Schmitz A; d'Amore F; Chan WC
BMC Genomics; 2007 Jul; 8():230. PubMed ID: 17623099
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence.
Trzonkowski P; Szmit E; Myśliwska J; Myśliwski A
Clin Immunol; 2006 Jun; 119(3):307-16. PubMed ID: 16545982
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T Cells Suppress Natural Killer Cell Immunity in Patients With Human Cervical Carcinoma.
Chang WC; Li CH; Chu LH; Huang PS; Sheu BC; Huang SC
Int J Gynecol Cancer; 2016 Jan; 26(1):156-62. PubMed ID: 26512789
[TBL] [Abstract][Full Text] [Related]
18. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation.
Vacca P; Martini S; Garelli V; Passalacqua G; Moretta L; Mingari MC
Eur J Immunol; 2013 Feb; 43(2):550-61. PubMed ID: 23192659
[TBL] [Abstract][Full Text] [Related]
19. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
[TBL] [Abstract][Full Text] [Related]
20. TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.
Hoste L; Roels L; Naesens L; Bosteels V; Vanhee S; Dupont S; Bosteels C; Browaeys R; Vandamme N; Verstaen K; Roels J; Van Damme KFA; Maes B; De Leeuw E; Declercq J; Aegerter H; Seys L; Smole U; De Prijck S; Vanheerswynghels M; Claes K; Debacker V; Van Isterdael G; Backers L; Claes KBM; Bastard P; Jouanguy E; Zhang SY; Mets G; Dehoorne J; Vandekerckhove K; Schelstraete P; Willems J; ; Stordeur P; Janssens S; Beyaert R; Saeys Y; Casanova JL; Lambrecht BN; Haerynck F; Tavernier SJ
J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34914824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
